Inspire Medical Systems INSP Income Statement (2017-2026)

NYSE INSP
$66.52 +4.38 (+7.05%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Inspire Medical Systems Quarterly Income Statement

Periods 38 quarters
Latest Jun 2026

Inspire Medical Systems reported revenue of $200.58M and net income of $0.31M for the quarter ended Jun 2026, down 7.6% year over year. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
61.69M78.40M69.38M91.39M109.19M137.90M127.90M151.09M153.30M192.51M164.01M195.88M203.19M239.72M201.32M217.09M224.50M269.08M204.58M200.58M
Cost of RevenueCost of Rev
8.62M11.16M10.00M14.17M19.79M22.15M19.89M24.25M24.38M28.05M24.76M29.84M32.40M35.99M30.71M34.67M31.77M36.07M27.67M29.12M
Gross Profit
53.06M67.24M59.38M77.21M89.40M115.75M108.01M126.84M128.92M164.45M139.25M166.04M170.79M203.73M170.61M182.41M192.73M233.01M176.91M171.46M
Operating items
Research & DevelopmentR&D
9.61M10.29M11.87M14.53M20.99M21.25M25.52M30.82M29.14M31.05M28.85M28.86M26.08M30.34M27.80M26.21M24.21M24.94M25.83M24.70M
Selling, General & AdministrativeSG&A
53.24M58.77M63.56M76.69M85.60M94.83M101.99M112.62M113.25M124.11M125.62M132.08M130.39M141.51M144.29M159.52M158.87M161.95M152.20M147.28M
Other Operating ExpensesOther Opex
Operating ExpensesOpex
62.86M69.06M75.43M91.22M106.60M116.08M127.51M143.44M142.39M155.16M154.47M160.94M156.47M171.85M172.09M185.73M183.08M186.90M178.03M171.97M
Operating IncomeOp. Inc
-9.80M-1.82M-16.06M-14.01M-17.19M-0.34M-19.50M-16.60M-13.47M9.30M-15.22M5.10M14.32M31.88M-1.49M-3.32M9.64M46.11M-1.12M-0.51M
EBIT
-9.80M-1.82M-16.06M-14.01M-17.19M-0.34M-19.50M-16.60M-13.47M9.30M-15.22M5.10M14.32M31.88M-1.49M-3.32M9.64M46.11M-1.12M-0.51M
Non-operating items
Non Operating Interest Expenses
0.54M0.54M0.53M0.49M0.66M0.02M0.00M0.01M0.12M
Non Operating Investment IncomeNon-Op. Investment Inc.
0.00M-0.05M-0.14M-0.04M-0.01M0.08M0.01M-0.00M0.12M0.61M-0.54M-0.20M1.56M-1.01M-0.01M-0.02M0.30M-0.05M
Interest & Investment IncomeInt & Inv Inc
0.02M0.01M0.03M0.30M1.35M3.37M4.27M4.92M5.50M5.87M5.92M5.88M5.89M5.55M5.07M4.48M3.98M4.00M3.74M3.74M
Other Non Operating IncomeOther Non Op Inc.
-0.03M-0.03M-0.04M-0.14M-0.10M0.24M0.02M-0.06M-0.22M0.07M-0.06M-0.14M0.12M-0.78M0.58M-3.50M-0.07M0.33M-0.23M-0.11M
Non Operating IncomeNon Op. Inc.
-0.55M-0.55M-0.54M-0.34M0.59M3.61M4.29M4.86M5.27M5.94M5.86M5.75M6.01M4.75M5.64M0.98M3.91M4.21M3.52M3.63M
Net income details
EBT
-10.34M-2.37M-16.59M-14.35M-16.60M3.27M-15.21M-11.74M-8.20M15.24M-9.36M10.85M20.33M36.64M4.16M-2.33M13.55M50.32M2.40M3.12M
Tax ProvisionsTaxes
0.00M-0.03M0.10M0.14M0.25M0.11M0.22M0.21M0.34M0.45M0.70M1.10M1.83M1.41M1.17M1.26M3.62M-85.77M13.69M2.80M
Profit After TaxPAT
-10.35M-2.44M-0.14M-0.00M-17.01M3.43M-15.42M-11.95M-8.60M14.76M-10.01M9.79M20.31M34.32M2.99M-3.59M10.18M135.99M-11.29M0.31M
Income from Continuing OperationsIncome (Continuing)
-10.35M-2.34M-16.69M-14.49M-16.85M3.16M-15.42M-11.95M-8.54M14.79M-10.05M9.75M18.50M35.22M2.99M-3.59M9.93M136.09M-11.29M0.31M
Consolidated Net IncomeConsol Net Inc.
-10.35M-2.34M-16.69M-14.49M-16.85M3.16M-15.42M-11.95M-8.54M14.79M-10.05M9.75M18.50M35.22M2.99M-3.59M9.93M136.09M-11.29M0.31M
Income towards Parent CompanyParent Net Inc
-10.35M-2.34M-16.69M-14.49M-16.85M3.16M-15.42M-11.95M-8.54M14.79M-10.05M9.75M18.50M35.22M2.99M-3.59M9.93M136.09M-11.29M0.31M
Net Income towards Common StockholdersNet Income
-10.35M-2.34M-16.69M-14.49M-16.85M3.16M-15.42M-11.95M-8.54M14.79M-10.05M9.75M18.50M35.22M2.99M-3.59M9.93M136.09M-11.29M0.31M
Additional items
EPS (Basic)
-0.38-0.09-0.61-0.53-0.600.11-0.53-0.41-0.290.50-0.340.330.621.180.10-0.120.344.63-0.390.01
EPS (Diluted)
-0.38-0.09-0.61-0.53-0.600.11-0.53-0.41-0.290.50-0.340.320.601.150.10-0.120.344.57-0.390.01
Shares Outstanding
27.30M27.26M27.52M27.59M28.23M28.07M29.09M29.23M29.37M29.30M29.62M29.73M29.88M29.76M29.70M29.51M29.33M29.37M28.70M28.84M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
27.30M27.26M27.52M27.59M28.23M28.07M29.09M29.23M29.37M29.30M29.62M30.41M30.63M30.54M30.31M29.51M29.60M29.76M28.70M28.94M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
27.35M27.42M27.57M27.63M28.82M29.01M29.16M29.33M29.40M29.56M29.68M29.81M29.96M29.74M29.47M29.57M29.05M28.58M28.80M28.91M
EBITDA
-9.80M-1.82M-16.06M-14.01M-17.19M-0.34M-19.50M-16.60M-13.47M9.30M-15.22M5.10M14.32M31.88M-1.49M-3.32M9.64M46.11M-1.12M-0.51M
Interest ExpensesInt Expense
0.54M0.54M0.53M0.49M0.66M0.02M0.00M0.01M0.12M
Tax Rate
-0.03%1.18%-0.60%-0.99%-1.48%3.45%-1.42%-1.82%-4.15%2.93%-7.48%10.14%9.00%3.85%28.06%-54.03%26.71%-170.45%571.17%89.92%